Executive Team

Pritesh Gandhi, PharmD

Chief Executive Officer

Pritesh Gandhi has a broad range of experiences in academia and the biopharmaceutical industry. Previously, he was General Manager at Alnylam Pharmaceuticals where he led cross-functional teams to bring forward a rare disease medicine from Phase 1/2 development to global commercialization. Earlier at Alnylam, Pritesh was responsible for building a world-class global medical affairs vision, strategy, and operational capability to launch two novel RNAi therapeutics. Prior to joining Alnylam, Pritesh had a wide-range of global medical affairs responsibilities in launching four first-in-class medicines in hematology/oncology at Genzyme Corporation (Sanofi Genzyme).

Pritesh launched his professional career in the biopharmaceutical industry at Millennium and then Alexion. He commenced his professional journey in academia with faculty appointments at Massachusetts College of Pharmacy and The University of Massachusetts Medical School where he conducted scholarly work and contributed to the medical literature.

Pritesh graduated with a Doctor of Pharmacy degree from Massachusetts College of Pharmacy and completed a residency at the University of Illinois at Chicago. He has received multiple awards for excellence in teaching, leadership, and community service.

Annie Partisano, PharmD, MS

SVP, Head of Operations

Angela (Annie) Partisano comes to TellBio with over 15 years of pharmaceutical industry experience in both pre-commercial and commercial companies. Previously, she was Vice President of Medical Operations at Kiniksa Pharmaceuticals, Ltd., where she was responsible for the operational growth of the Medical Affairs team. Prior to joining Kiniksa, Annie held several positions of increasing responsibility within the Medical Affairs team at Alnylam Pharmaceuticals where she helped build a world-class global medical affairs vision, strategy, and operational capability and supported the launch of two novel RNAi therapeutics. Earlier in her career, Annie held leadership positions within the Medical Affairs teams at Genzyme Corporation (Sanofi Genzyme) and Boehringer Ingelheim Pharmaceuticals, Inc.

During her professional career, Annie has been recognized for establishing industry leading Medical functions as well as top-tier Medical Affairs Post-PharmD Fellowship programs in the Boston area. In 2018, Annie was named one of the Healthcare Businesswomen’s Association (HBA) Rising Star for her noteworthy achievements within the pharmaceutical industry.

Annie received her Doctor of Pharmacy degree as well as her Master of Science (Regulatory Affairs) from Northeastern University and completed post-doctorate residencies at the University of Rochester and Purdue University/Eli Lilly.

BOARD OF DIRECTORS

Richard Peters, MD, PhD

Executive Chairman, TellBio
Chairman, Pharming Group
Chairman, Aprea Therapeutics
Director, Kineta

Gary Crocker, MBA

Director, TellBio
President, Crocker Ventures
Chairman, Merrimack Pharmaceuticals
Chairman, Nexus Spine

Bernard Peters, MIBS

Director, TellBio
Chief Financial Officer, Sloan
President, Sloan Flushmate

Pritesh Gandhi, PharmD

Chief Executive Officer, TellBio

FOUNDERS

Richard Peters, MD, PhD

Executive Chairman, TellBio
Chairman, Pharming Group
Chairman, Aprea Therapeutics
Director, Kineta

Daniel Haber, MD, PhD

Director, Massachusetts General Hospital Cancer Center

Professor of Oncology, Harvard Medical School

Mehmet Toner, PhD

Co-Director, MGH Center for Engineering in Medicine & Surgery

Professor of Biomedical Engineering, Harvard Medical School

David Ting, MD

Associate Professor, Massachusetts General Hospital and Harvard Medical School

Associate Clinical Director for Innovation, Massachusetts General Hospital Cancer Center

Shyamala Maheswaran, PhD

Professor of Surgery, Harvard Medical School

Scientific Director, Massachusetts General  Hospital Laboratory for CTC Innovation

Ravi Kapur, PhD

CEO, BendBio Inc.
President, Boston Nanotech Inc.

Scroll to Top